About Able Laboratories
Able Laboratories is a Healthcare/Pharmaceuticals / Drugs company based in Cranbury, New Jersey. Able Laboratories' investors include SF Capital Partners, Highline Capital Management, Oberweis Funds, Rx Capital Management, UBS, Wells Fargo Equity Capital, Bank of Bermuda, Perry Capital, Mainfield Enterprises, Schroder Investment Management, Downsview Capital, Oberweis Asset Management and Highbridge Capital Management.
Missing: Able Laboratories's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Able Laboratories's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Able Laboratories Frequently Asked Questions (FAQ)
When was Able Laboratories founded?
Able Laboratories was founded in 1988.
Where is Able Laboratories's headquarters?
Able Laboratories's headquarters is located at 1 Able Drive, Cranbury.
What is Able Laboratories's latest funding round?
Able Laboratories's latest funding round is Unattributed VC - III.
How much did Able Laboratories raise?
Able Laboratories raised a total of $38.7M.
Who are the investors of Able Laboratories?
Investors of Able Laboratories include Downsview Capital, Rx Health Management, Highline Capital Management, SF Capital Group, UBS and 10 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.